Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease

Kathryn L. Pothoven, James E. Norton, Kathryn E. Hulse, Lydia A. Suh, Roderick G. Carter, Erin Rocci, Kathleen E. Harris, Stephanie Shintani-Smith, David B. Conley, Rakesh K. Chandra, Mark C. Liu, Atsushi Kato, Nirmala Gonsalves, Leslie C. Grammer, Anju T. Peters, Robert C. Kern, Paul J. Bryce, Bruce K. Tan, Robert P. Schleimer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

111 Scopus citations

Fingerprint

Dive into the research topics of 'Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology